Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 29:148:e119.
doi: 10.1017/S0950268820000229.

Dengue virus co-infections with multiple serotypes do not result in a different clinical outcome compared to mono-infections

U T N Senaratne  1   2 , K Murugananthan  1   3 , P D N N Sirisena  1 , J M Carr  4 , F Noordeen  1
Affiliations

Dengue virus co-infections with multiple serotypes do not result in a different clinical outcome compared to mono-infections

U T N Senaratne et al. Epidemiol Infect. .

Abstract

Circulation of multiple dengue virus (DENV) serotypes in a locale has resulted in individuals becoming infected with mixed serotypes. This research was undertaken to study the clinical presentation, presence of DENV serotypes and serological characteristics of DENV infected patients with co-infections from three Provinces of Sri Lanka where DENV-1 and -2 predominated during the study. A reverse transcription polymerase chain reaction was performed on 1249 patient samples and 301 were positive for DENV (24.1%). DENV-1 was the predominant serotype detected in 137 (45.51%) followed by DENV-2 in 65 (21.59%), DENV-3 in 59 (19.6%) and DENV-4 in 4 (1.32%) patients with mono-infections. Thirty-three patients (10.96%) had DENV co-infections with two or more serotypes. The highest number of co-infections was noted between DENV-1 and DENV-2 (57.57%) suggesting co-infection is driven by the frequency of the circulating serotypes. Platelet counts were significantly higher in DENV co-infected patients although clinical disease severity or white blood cell count, packed cell volume or viraemia were not significantly different in the co-infected compared to the mono-infected patients. Thus co-infection with multiple DENV serotypes does occur but with the exception of improved platelet counts in co-infected patients, there is no evidence that clinical or laboratory measures of disease are altered.

Keywords: DENV co-infections; Dengue; RT-PCR; Sri Lanka.

PubMed Disclaimer

Conflict of interest statement

‘None.’

Figures

Fig. 1.
Fig. 1.
A flow diagram illustrating the detection of DENV infection followed by the detection of DENV mono and co-infections in the study sample; testing subsets of patients' samples using the RT-qPCR for DENV quantification and amplification by culture and DENV sero-typing.
Fig. 2.
Fig. 2.
Comparison of WBC counts between DENV mono- and co-infections analysed by the Mann–Whitney test – DENV-1 (n = 137); DENV-2 (n = 65); DENV-3 (n = 59); DENV-4 (n = 6); DENV-1 + DENV-2 (n = 11); DENV-1 + DENV-3 (n = 13); DENV-1 + DENV-4 (n = 1); DENV-2 + DENV-3 (n = 6); DENV-3 + DENV-4 (n = 1); DENV-1 + DENV-3 + DENV-4 (n = 1). DENV is given as D in the figure and that D1 = DENV-1, D2 = DENV-2, D3 = DENV-3 and D4 = DENV-4.
Fig. 3.
Fig. 3.
Comparison of platelet counts between DENV mono- and co-infections analysed by the Mann–Whitney test – DENV-1 (n = 137); DENV-2 (n = 65); DENV-3 (n = 59); DENV-4 (n = 6); DENV-1 + DENV-2 (n = 11); DENV-1 + DENV-3 (n = 13); DENV-1 + DENV-4 (n = 1); DENV-2 + DENV-3 (n = 6); DENV-3 + DENV-4 (n = 1); DENV-1 + DENV-3 + DENV-4 (n = 1); statistically significant*. DENV is given as D in the figure and that D1 = DENV-1, D2 = DENV-2, D3 = DENV-3 and D4 = DENV-4.
Fig. 4.
Fig. 4.
Comparison of PCV between DENV mono- and co-infections analysed by the Mann–Whitney test – DENV-1 (n = 137); DENV-2 (n = 65); DENV-3 (n = 59); DENV-4 (n = 6); DENV-1 + DENV-2 (n = 11); DENV-1 + DENV-3 (n = 13); DENV-1 + DENV-4 (n = 1); DENV-2 + DENV-3 (n = 6); DENV-3 + DENV-4 (n = 1); DENV-1 + DENV-3 + DENV-4 (n = 1). DENV is given as D in the figure and that D1 = DENV-1, D2 = DENV-2, D3 = DENV-3 and D4 = DENV-4.
Fig. 5.
Fig. 5.
Comparison of the viral load between mono- and co-infections with different DENV serotypes (38 patients' samples were subjected to the quantitative RT-PCR using the capsid gene primers) [20]. DENV is given as D in the figure and that D1 = DENV-1, D2 = DENV-2, D3 = DENV-3 and D4 = DENV-4.
See this image and copyright information in PMC

References

    1. Senaratne TN and Noordeen F (2014) Diagnosis of dengue in Sri Lanka: improvements to the existing state of the art in the island. Transactions of the Royal Society of Tropical Medicine and Hygiene 108, 685–691. - PubMed
    1. Sirisena PD and Noordeen F (2014) Evolution of dengue in Sri Lanka-changes in the virus, vector, and climate. Internatioal Journal of Infectious Diseases 19, 6–12. - PubMed
    1. Kanakaratne N et al. (2009) Severe dengue epidemics in Sri Lanka, 2003–2006. Emerging Infectious Diseases 15, 192–199. - PMC - PubMed
    1. Messer WB et al. (2003) Emergence and global spread of a dengue serotype 3, subtype III virus. Emerging Infectious Diseases 9, 800–809. - PMC - PubMed
    1. Senaratne T et al. (2016) Characterization of dengue virus infections in a sample of patients suggests unique clinical, immunological, and virological profiles that impact on the diagnosis of dengue and dengue hemorrhagic fever. Journal of Medical Virology 88, 1703–1710. - PubMed

Publication types